Buy Mounjaro Online
Buy Mounjaro Online is a highly effective, UK licensed weight loss treatment. It has been shown in clinical trials to help achieve up to 22.5% body weight loss. It is the latest GLP-1 weight loss medication, and is used for people with a body mass index (BMI) over 30. It can also be prescribed for patients with a BMI of 27+ and a weight-related medical condition, such as high blood pressure or high cholesterol.
The active ingredient tirzepatide is a registered trademark of Eli Lilly.
It is known as Zepbound in the US, but launched in the UK under the brand name Mounjaro.
It is used ONCE weekly, as a subcutaneous (under the skin) injection. More information on how to inject Mounjaro can be found in the Patient Information Leaflet.
Buy Mounjaro Online
The active ingredient tirzepatide works by activating the receptors of 2 natural incretin hormones: GIP and GLP-1. Both of these hormones affect your appetite by slowing down the emptying of the stomach after a meal. They also send signals to your brain to reduce your appetite after eating. This action creates a feeling of being full and so makes you feel less hungry, even when you have eaten less, which can aid in weight loss.
For diabetic patients, Mounjaro increases the production of insulin, which is released into your body to lower blood sugar levels.
Mounjaro is an effective treatment for both weight loss and regulating blood sugar levels. A recent clinical trial has shown that people who used Mounjaro lost up to 22.5% of their body weight on the highest maintenance dose (15mg tirzepatide, once per week) within 72 weeks..
-
Where should I inject Mounjaro?
Mounjaro can be injected either in the abdomen or thigh. Select an injection site that you feel most comfortable with. Switch injection sites weekly and divide the chosen area into four sections which will be your injection sites. Inject at least one finger width away from the last injection. If injecting in the abdomen, inject at least 5cm away from the navel.



Reviews
There are no reviews yet.